Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease
Open Access
- 7 January 2019
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 10 (5) , 495-508
Abstract
Active transport of microRNAs (miRNA) in extracellular vesicles (EV) occurs in disease. Circulating EV-packaged miRNAs in the serum of stroke patients were compared to stroke mimics with matched cardio- and cerebrovascular risk factors, with corroboration of results in a pre-clinical model. An unbiased miRNA microarray was performed in stroke vs. stroke mimic patients (n = 39). Results were validated (n = 173 patients) by real-time quantitative polymerase chain reaction. miRNA expression was quantified in total serum/EV (n = 5–7) of naïve adult spontaneously hypertensive stroke-prone rats (SHRSP), their normotensive reference strain (Wistar Kyoto, WKY) and in circulating EV (n = 3), peri-infarct brain (n = 6), or EV derived from this region (n = 3) in SHRSP following transient middle cerebral artery occlusion (tMCAO). Circulating EV concentration did not differ between stroke and stroke mimic patients. The microarray identified many altered EV-packaged miRNAs: levels of miRNA-17-5p, -20b-5p and -93-5p (miRNA-17 family members) and miRNA-27b-3p were significantly (p ≤ 0.05) increased in stroke vs. stroke mimic patients. Patients with small vessel disease (SVD) consistently had the highest miRNA levels. Circulating EV concentration was unaltered between naïve SHRSP and WKY but levels of miRNA-17-5p and -93-5p were significantly increased in SHRSP. tMCAO in SHRSP did not further alter circulating EV miRNA-17 family member expression and nor did it change total miRNA-17 family levels in peri-infarct brain tissue or in EV isolated from this region at 24 h post-tMCAO. Changes in EV packaged miRNA expression was validated in patients with stroke, particularly those with SVD and corroborated pre-clinically. Together, altered circulating EV levels of miRNA-17 family members may reflect the chronic sequelae underlying cerebrovascular SVD rather than the acute ischemic stroke itself.Keywords
Funding Information
- British Heart Foundation (RE/13/5/30177, FS/15/64/32035)
- Medical Research Council (MR/K500847/1, G1100562)
- R.S. MacDonald Charitable Trust
This publication has 31 references indexed in Scilit:
- Mechanisms of sporadic cerebral small vessel disease: insights from neuroimagingThe Lancet Neurology, 2013
- The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular SpaceJournal of Biological Chemistry, 2012
- Positive impact of pre-stroke surgery on survival following transient focal ischemia in hypertensive ratsJournal of Neuroscience Methods, 2012
- The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in ExosomesPLOS ONE, 2012
- Expression Profile of MicroRNAs in Young Stroke PatientsPLOS ONE, 2009
- Potential Animal Models of Lacunar StrokeStroke, 2009
- Biological principles of microRNA-mediated regulation: shared themes amid diversityNature Reviews Genetics, 2008
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993